Please join your friends and colleagues as we host a group of leading Hungarian biotechnology executives and entrepreneurs on their visit to the Bay Area. They will be accompanied by the heads of the governmental agencies responsible for inbound and outbound biotechnology investments. Members of this delegation would like to meet their counterparts in the Bay Area biotechnology community in order to establish strategic relationships in the following areas:
- Licensing, collaborative research, and development projects
- Contract development, testing, and distribution arrangements
- Securing dependable and cost-efficient sources of clinical trials
Related Insights
July 22, 2025
Health Care Law Today
GLP-1 Receptor Agonists: Clinical Trial Considerations
The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide (Victoza®), semaglutide (Ozempic®, Wegovy®), and tirzepatide (Mounjaro®, Zepbound®).
July 21, 2025
Energy Current
DOE Announces Pilot Program to Build Advanced U.S. Nuclear Fuel Supply Lines: What You Need to Know Now
Introduction Coming on the heels of its June 2025 announcement establishing a pilot program for reactor construction and operation in…
July 21, 2025
Labor & Employment Law Perspectives
Considering a Reduction in Force? Some Preliminary Considerations
Employers sometimes find it necessary to make the difficult decision to undergo a reduction-in-force (RIF), resulting in employee layoffs…